FDA Approved: BIZENGRI — Original Application (Merus US, Inc.)

View source ↗

Summary

The FDA approved Bizengri (zenocutuzumab) from Merus US, Inc. in an Original Application for adult patients with NRG1 fusion-positive solid tumors, marking a fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nrg1 Fusion-positive Solid Tumors

Drugs mentioned

• BIZENGRI (ZENOCUTUZUMAB)

Snippet

ORIG AP for BIZENGRI (ZENOCUTUZUMAB)